TBC1D16 and melanoma: Network and/or module based approaches also proved to be powerful in pinpointing disease causing genes, many of which, for example Ppm1l for metabolic syndrome or TBC1D16 and RAB27A for melanoma (Akavia et al., 2010), have been confirmed experimentally while others are supported by literature evidences.